Jill Waibel, MD
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:IpsenTopic:Clinical TrialDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Janssen / J&JTopic:Clinical TrialDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:KenvueTopic:Scientific Advisory BoardDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:LumenisTopic:Scientific Advisory Board / Consultant / SpeakerDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:NovartisTopic:Clinical TrialDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:PfizerTopic:Clinical TrialDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:RegenXTopic:Consultant, Clinical TrialDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:SanofiTopic:Clinical TrialDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:SkinCeuticalsTopic:Clinical Trial, Consultant, Scientifc Advisory BoardDate added:07/27/2026Date updated:07/27/2026
-
Attribution:SelfType of financial relationship:ResearcherIneligible company:Shanghai BiopharmaTopic:Clinical Trial PWSDate added:07/27/2026Date updated:07/27/2026

Facebook
X
LinkedIn
Forward